US Capitol Capsule: Allies offer Alzheimer’s advice: Combo attack
This article was originally published in Scrip
Executive Summary
At the end of a three-day meeting last week in Washington, high-ranking US government officials joined patient groups and academic leaders advocating for greater Alzheimer's disease research and better strategies for drug development in declaring that combination therapies, which have become the hallmark for treating HIV/AIDS, many cancers and tuberculosis, should be pursued as the new plan of attack against the progressive fatal neurodegenerative disorder, which robs people of their memories, independence and identity.